Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDCA vs UDCA + Immunosuppressants in PBC-AIH Overlap Syndrome
NCT02936596Unknown
- Start
- Dec 2016
- Primary completion
- Jun 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of methylprednisolone and azathioprine in Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (AIH-PBC) (2 arms). Primary endpoint: Percent of patients that achieve biochemical remission of autoimmune hepatitis at Month 6. Status: unknown.
02
Drugs
methylprednisoloneazathioprine
03
Conditions
Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (AIH-PBC)
Beyond the preview
Go deeper on NCT02936596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02936596.